| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2012-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774480879738fcdb244bcf6d452394d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bf52ca55437b5b0a9416953fa8f566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b41e1eb37661ad7aaa80ea7ed3b321b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e290f29f1c805b90f7ebc43b9b3364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d4f8c9fdc24b6c3fe2687d4ea31be3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e2eee887fd16f255cb133f5e7e215d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92a710b13f403211fd49cd252782bad8 |
| publicationDate |
2020-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-034583-B1 |
| titleOfInvention |
APPLICATIONS ANTI-α4β7 ANTIBODIES |
| abstract |
The invention relates to the use of an anti-α4β7 antibody for the treatment of Crohn's disease and ulcerative colitis by intravenous administration in a safe dosage regimen. |
| priorityDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |